Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2019 (704 publications)

no pagination
Bamias A, Tzannis K, Bamia C, Harshman LC, Crabb S, Plimack ER, Pal S, De Giorgi U, Ladoire S, Theodore C, Agarwal N, Yu EY, Niegisch G, Sternberg CN, Srinivas S, Vaishampayan U, Necchi A, Liontos M, Rosenberg JE, Powles T, Bellmunt J, Galsky MD. The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer. The oncologist. 2019 Oct;24(10):1348-55.   PMCID: PMC6795165
Bodor JN, Feliciano JL, Edelman MJ. Corrigendum to "Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation" [Lung Cancer 135 (September) (2019) 16-20]. Lung Cancer. 2019 Oct;136:157.
Brickman C, Propert K, Merlin J, Liu J, Eady S, McGhee-Jez A, Ragin C, Grover S, Cohen R, Gross R. Treatment and Outcomes of Oropharyngeal Cancer in Patients with Human Immunodeficiency Virus. AIDS research and human retroviruses. 2019 Oct;35(10):934-40.   PMCID: PMC6806360
Daly MB. Prostate cancer genetic testing: NCCN familial high-risk assessment: breast/ovarian. The Canadian journal of urology. 2019 Oct;26(5s2):29-30.
Edelman MJ, Redman MW, Albain KS, McGary EC, Rafique NM, Petro D, Waqar SN, Minichiello K, Miao J, Papadimitrakopoulou VA, Kelly K, Gandara DR, Herbst RS. SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy). J Thorac Oncol. 2019 Oct;14(10):1853-9.   PMCID: PMC6764876
Fang CY, Egleston BL, Byrne C, Bohr GS, Pathak HB, Godwin AK, Siu PT, Tseng M. Inflammation and breast density among female Chinese immigrants: exploring variations across neighborhoods. Cancer causes & control : CCC. 2019 Oct;30(10):1113-26.   PMCID: PMC6745706
Fang P, Li X, Shan H, Saredy JJ, Cueto R, Xia J, Jiang X, Yang XF, Wang H. Ly6C(+) Inflammatory Monocyte Differentiation Partially Mediates Hyperhomocysteinemia-Induced Vascular Dysfunction in Type 2 Diabetic db/db Mice. Arteriosclerosis, thrombosis, and vascular biology. 2019 Oct;39(10):2097-119.   PMCID: PMC6761027
Friebel TM, Andrulis IL, Balmana J, Blanco AM, Couch FJ, Daly MB, Domchek SM, Easton DF, Foulkes WD, Ganz PA, Garber J, Glendon G, Greene MH, Hulick PJ, Isaacs C, Jankowitz RC, Karlan BY, Kirk J, Kwong A, Lee A, Lesueur F, Lu KH, Nathanson KL, Neuhausen SL, Offit K, Palmero EI, Sharma P, Tischkowitz M, Toland AE, Tung N, van Rensburg EJ, Vega A, Weitzel JN, Hoskins KF, Maga T, Parsons MT, McGuffog L, Antoniou AC, Chenevix-Trench G, Huo D, Olopade OI, Rebbeck TR. BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry. Hum Mutat. 2019 Oct;40(10):1781-96.   PMCID: PMC6764847
Gasoyan H, Halpern MT, Tajeu G, Sarwer DB. Impact of insurance plan design on bariatric surgery utilization. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2019 Oct;15(10):1812-8.   PMCID: PMC6834903
Gershman B, Maroni P, Tilburt JC, Volk RJ, Konety B, Bennett CL, Kutikov A, Smaldone MC, Chen V, Kim SP. A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer. World journal of urology. 2019 Oct;37(10):2099-108.
Herman AB, Silva Afonso M, Kelemen SE, Ray M, Vrakas CN, Burke AC, Scalia RG, Moore K, Autieri MV. Regulation of Stress Granule Formation by Inflammation, Vascular Injury, and Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2019 Oct;39(10):2014-27.   PMCID: PMC6761003
Holt K, Ye M, Nagar S, Korzekwa KR. Prediction of tissue - plasma partition coefficients using microsomal partitioning: Incorporation into physiologically-based pharmacokinetic models and steady state volume of distribution predictions. Drug metabolism and disposition: the biological fate of chemicals. 2019 Oct;47(10):1050-60.   PMCID: PMC6750188
Howell K, Matuszak M, Maitz CA, Eisaman SH, Padilla L, Brown SL, Joiner MC, Dominello MM, Burmeister J. Three Discipline Collaborative Radiation Therapy (3DCRT) special debate: In the future, at least 20% of NIH funding for radiotherapy research should be allocated to non-oncologic applications. J Appl Clin Med Phys. 2019 Oct;.   PMCID: Editorial
Hung A, Li Y, Keefe FJ, Ang DC, Slover J, Perera RA, Dumenci L, Reed SD, Riddle DL. Ninety-day and one-year healthcare utilization and costs after knee arthroplasty. Osteoarthritis and cartilage. 2019 Oct;27(10):1462-9.   PMCID: PMC6750955
Kantor O, Chang C, Bleicher RJ, Moran M, Connolly JL, Kurtzman SH, Yao K. Physician Knowledge of Breast Cancer Recurrence and Contralateral Breast Cancer Risk is Associated with Increased Recommendations for Contralateral Prophylactic Mastectomy: a Survey of Physicians at NAPBC-Accredited Centers. Ann Surg Oncol. 2019 Oct;26(10):3080-8.
Kumar SK, Callander NS, Hillengass J, Liedtke M, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Cornell RF, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Holmberg L, Htut M, Huff CA, Kang Y, Landgren O, Malek E, Martin T, Omel J, Raje N, Sborov D, Singhal S, Stockerl-Goldstein K, Tan C, Weber D, Johnson-Chilla A, Keller J, Kumar R. NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020. Journal of the National Comprehensive Cancer Network : JNCCN. 2019 Oct;17(10):1154-65.
Lieu CH, Golemis EA, Serebriiskii IG, Newberg JY, Hemmerich A, Connelly C, Messersmith WA, Eng C, Eckhardt SG, Frampton GM, Cooke M, Meyer JE. Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer. Clin Cancer Res. 2019 Oct;25(19):5852-8.   PMCID: PMC6774873
Motzer RJ, Rini BI, McDermott DF, Aren Frontera O, Hammers HJ, Carducci MA, Salman P, Escudier B, Beuselinck B, Amin A, Porta C, George S, Neiman V, Bracarda S, Tykodi SS, Barthelemy P, Leibowitz-Amit R, Plimack ER, Oosting SF, Redman B, Melichar B, Powles T, Nathan P, Oudard S, Pook D, Choueiri TK, Donskov F, Grimm MO, Gurney H, Heng DY, Kollmannsberger CK, Harrison MR, Tomita Y, Duran I, Grunwald V, McHenry MB, Mekan S, Tannir NM. Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial. Lancet Oncol. 2019 Oct;20(10):1370-85.
Park PH, Yamamoto TM, Li H, Alcivar AL, Xia B, Wang Y, Bernhardy AJ, Turner KM, Kossenkov AV, Watson ZL, Behbakht K, Casadei S, Swisher EM, Mischel PS, Johnson N, Bitler BG. Amplification of the mutation-carrying BRCA2 allele promotes RAD51 loading and PARP inhibitor resistance in the absence of reversion mutations. Mol Cancer Ther. 2019 Oct;.
Pazina T, James AM, Colby KB, Yang Y, Gale A, Jhatakia A, Kearney AY, Graziano RF, Bezman NA, Robbins MD, Cohen AD, Campbell KS. Enhanced SLAMF7 homotypic interactions by elotuzumab improves NK cell killing of multiple myeloma. Cancer Immunol Res. 2019 Oct;7(10):1633-46.   PMCID: PMC6774869
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2019


Last updated on Wednesday, February 05, 2020